Media & news

Invitation to the Shareholders of Nobel Biocare Holding Ltd. to the Extraordinary Shareholders’ Meeting  

Monday, December 15, 2014 at 3:00 p.m. (doors open at 2:45 p.m.) Balsberg, Balz Zimmermann-Strasse 7, CH-8302 Kloten 

AGENDA

1    Discharge of the Board of Directors

2    Elections

      2.1 Election of the members to the Board of Directors and of the Chairman to the

            Board of Directors

      2.2 Election of the Compensation Committee

The complete invitation is published in the Swiss Official Gazette of Commerce on November 21, 2014 and is accessible on the Company’s website (www.nobelbiocare.com).

Nobel Biocare Holding Ltd.

On behalf of the Board of Directors

Rolf Watter, Chairman

Nobel Biocare is a world leader in the field of innovative implant-based dental restorations. The company’s portfolio offers solutions from single tooth to fully edentulous indications with dental implant systems (including key brands NobelActive®, Brånemark System® and NobelReplace®), a comprehensive range of high-precision individualized prosthetics and CAD/CAM systems (NobelProcera®), diagnostics, treatment planning and guided surgery solutions (NobelClinician® and DTX Studio™) and biomaterials (creos). Nobel Biocare supports its customers through all phases of professional development, offering world-class training and education along with practice support and patient information materials. The company is headquartered in Zurich, Switzerland. Production takes place at six sites located in the United States, Sweden, Japan and Israel. Products and services are available in over 80 countries through subsidiaries and distributors.